International Health Insurance

September 20, 2021

Yusimry Approved as Humira Biosimilar

December 20, 2021 – YusimryTM (adalimumab-aqvh), manufactured by Coherus BioSciences, has been approved as a biosimilar for AbbVie's Humira® (adalimumab)
September 16, 2021
Lymphoma-Indications

Brukinsa Receives Two New Lymphoma Indications

September 16, 2021 – The U.S. FDA has approved two new indications for Brukinsa® (zanubrutinib), the first to treat adults who have Waldenström's macroglobulinemia